Premarket Mover: Moderna Inc (MRNA) Down 2.55%

Moderna Inc (MRNA) has fallen Tuesday morning, with the stock losing -2.55% in pre-market trading to 199.5. MRNA's short-term technical score of 61 indicates that the stock has traded more bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 91% of stocks. Moderna Inc has fallen 30.55% over the past month, closing at $268.14 on December 21. During this period of time, the stock fell as low as $204.73 and as high as $281.30. MRNA has an average analyst recommendation of Buy. The company has an average price target of $257.23.

MRNA has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on MRNA!

See Full MRNA Report

Moderna Inc has a Long-Term Technical rank of 37. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 63% of the market scoring higher. In the Biotechnology industry which is number 143 by this metric, MRNA ranks better than 76% of stocks.

Important Dates for Investors in MRNA:

-Moderna Inc is set to release earnings on 2/2/2022. During their last earnings release the company posted EPS of $16.30. -We do not have a set dividend date for Moderna Inc at this time. Click Here To Get The Full Report on Moderna Inc (MRNA)